RUXCOVID: A phase 3, randomized, placebo-controlled study evaluating the efficacy and safety of ruxolitinib in patients with COVID-19-associated cytokine storm

Han, MeiLan K.; Ignacio, Rachel Ann Bender; Lopez Bernus, Amparo; Milger-Kneidinger, Katrin; Nyaku, Amesika N.; Parker, Ben; Potter, Victoria; Savic, Sinisa; Campello-Iddison, Valerie; Cao, Weihua; Langmuir, Peter; Knorr, Barbara

Han, MeiLan K.; Ignacio, Rachel Ann Bender; Lopez Bernus, Amparo; Milger-Kneidinger, Katrin; Nyaku, Amesika N.; Parker, Ben; Potter, Victoria; Savic, Sinisa; Campello-Iddison, Valerie; Cao, Weihua; Langmuir, Peter; Knorr, Barbara.

Clinical Cancer Research ; 26(18), 2020.

Article in English | Web of Science | ID: covidwho-839754

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies / Randomized controlled trials Language: English Journal: Clinical Cancer Research Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML